Format

Send to

Choose Destination
J Diabetes Complications. 2007 Jul-Aug;21(4):220-6.

Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

Author information

1
Department of Family Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Abstract

BACKGROUND:

Many patients with Type 2 diabetes require treatment with insulin but do not receive it.

AIM:

To examine the barriers that hinder the transition to insulin from the point of view of patients and family physicians.

METHODS:

PATIENTS:

Study group (SG)-92 patients who need insulin (maximum oral medications and HbA(1c)>8.5%). Control group (CG)-101 patients who had begun insulin medication recently. PATIENTS were interviewed about attitudes and beliefs regarding their illness and insulin treatment. Physicians: 157 family physicians completed a questionnaire regarding barriers to insulin treatment and answered an open-ended question about the criteria for starting insulin.

RESULTS:

In comparing between barriers of SG patients and perspectives of the CG patients, SG patients perceived their illness as not very serious (46.7% vs. 7%, P<.0001), had more fear of addiction to insulin (39% vs. 20.8%, P<.01) and hypoglycemia (12% vs. 4%, P=.05), and perceived the quality of their treatment worse (P<.001). Pain associated with injection and blood tests ranked low. Only 44.3% of physicians specified two criteria or more for treatment with insulin. Physicians' main barriers for commencing insulin medication were as follows: patients' compliance (92.3%), hypoglycemia (79.9%), coping with pain associated with blood tests (53.9%), and pain associated with injections (47.4%).

CONCLUSION:

Physicians' knowledge was relatively low, and they assign much more importance to the physical fears of patients and are not sufficiently aware of patients' misconceptions regarding the seriousness of their condition and concerns of addiction. This gap apparently contributes to the delay or even the prevention of commencing insulin medication.

PMID:
17616351
DOI:
10.1016/j.jdiacomp.2006.02.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center